News | April 18, 2025
CCI approves merger between Aster DM Healthcare and Quality Care India
The merged entity ‘Aster DM Quality Care’ will be jointly controlled by Aster Promoters and Blackstone
The merged entity ‘Aster DM Quality Care’ will be jointly controlled by Aster Promoters and Blackstone
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
David joins HCTI with a distinguished career of over 22 years of corporate finance experience
This approval marks a significant milestone in OneSource’s ongoing commitment to quality and regulatory compliance
In light of the contributions of these three institutes, it was decided to organize a CSIR Startup Conclave in Hyderabad. The event, scheduled for April 22–23, 2025
Approval brings AstraZeneca and Daiichi Sankyo’s Enhertu earlier in the treatment of HR-positive, HER2-low breast cancer and broadens the eligible patient population to those with HER2-ultralow disease
Bloom has pioneered a technology to transform plant waste into valuable chemical products
AstraZeneca Pharma India discontinues manufacturing of Imdur
The amalgamation is expected to create a future-ready, diversified CDMO platform with a technology-led focus across three high-growth verticals-Antibody Drug Conjugates
Alembic Pharmaceuticals Ltd. and Amlan International sign exclusive strategic commercial agreement to make poultry health innovations accessible to Indian farmers and integrators
Subscribe To Our Newsletter & Stay Updated
